Oncad for DynaCAD is an FDA-cleared, fully automated morphological system for the detection and analysis by a radiologist of suspicious breast lesions. It uses a patented mathematical algorithm to analyze the entire breast and draw a physician’s attention to abnormal morphology during a contrast-enhanced breast MRI. This approach also delineates the extent of the disease by measuring margin sharpness to determine the degree of lesion vascularization. The suspicious lesions are marked with a color overlay, light pink for moderate suspicion and dark pink for highly suspicious lesions.
For more information: www.invivocorp.com
August 21, 2026 
